Tonix Pharmaceuticals Says It Is Developing A Vaccine Candidate Called TNX-801 As WHO Declared MPOX A Public Health Emergency Of International Concern On Aug. 14
Tonix Pharmaceuticals Says It Is Developing A Vaccine Candidate Called TNX-801 As WHO Declared MPOX A Public Health Emergency Of International Concern On Aug. 14
tonix pharmaceuticals表示正在開發一個名爲TNX-801的疫苗候選者，因爲世界衛生組織於8月14日宣佈MPOX爲國際關注的公共衛生緊急事件。
Tonix has successfully completed non-human primate studies showing protection from challenge with lethal doses of the Clade 1 monkeypox virus that is driving the new epidemic.
Tonix成功完成了非人類靈長類動物研究，這些研究表明，使用致命劑量的Clade 1猴痘病毒可以抵禦挑戰，這種病毒正在推動新的流行病。
Clearly more testing is ahead for TNX-801, but the technology behind it is rooted in the science of Edward Jenner's smallpox vaccine of the late 1700s, the only vaccine to successfully eradicate a contagious viral pathogen.
顯然，TNX-801 還有更多測試要進行，但其背後的技術植根於愛德華·詹納在1700年代末的天花疫苗的科學，這是唯一成功根除傳染性病毒病原體的疫苗。